These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12950256)

  • 1. Transient increase of the labile iron pool in HepG2 cells by intravenous iron preparations.
    Sturm B; Goldenberg H; Scheiber-Mojdehkar B
    Eur J Biochem; 2003 Sep; 270(18):3731-8. PubMed ID: 12950256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The labile iron pool in hepatocytes: prooxidant-induced increase in free iron precedes oxidative cell injury.
    Stäubli A; Boelsterli UA
    Am J Physiol; 1998 Jun; 274(6):G1031-7. PubMed ID: 9696702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of the cytosolic chelatable iron pool of K562 cells.
    Breuer W; Epsztejn S; Cabantchik ZI
    FEBS Lett; 1996 Mar; 382(3):304-8. PubMed ID: 8605990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The labile iron pool: characterization, measurement, and participation in cellular processes(1).
    Kakhlon O; Cabantchik ZI
    Free Radic Biol Med; 2002 Oct; 33(8):1037-46. PubMed ID: 12374615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous iron preparations and ascorbic acid: effects on chelatable and bioavailable iron.
    Sturm B; Laggner H; Ternes N; Goldenberg H; Scheiber-Mojdehkar B
    Kidney Int; 2005 Mar; 67(3):1161-70. PubMed ID: 15698458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation.
    Scheiber-Mojdehkar B; Lutzky B; Schaufler R; Sturm B; Goldenberg H
    J Am Soc Nephrol; 2004 Jun; 15(6):1648-55. PubMed ID: 15153577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular labile iron pool and intracellular ferritin in K562 cells.
    Konijn AM; Glickstein H; Vaisman B; Meyron-Holtz EG; Slotki IN; Cabantchik ZI
    Blood; 1999 Sep; 94(6):2128-34. PubMed ID: 10477743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ratiometric iron probe enables investigation of iron distribution within tumour spheroids.
    Carney IJ; Kolanowski JL; Lim Z; Chekroun B; Torrisi AG; Hambley TW; New EJ
    Metallomics; 2018 Apr; 10(4):553-556. PubMed ID: 29658547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG.
    Gaboriau F; Leray AM; Ropert M; Gouffier L; Cannie I; Troadec MB; Loréal O; Brissot P; Lescoat G
    Biometals; 2010 Apr; 23(2):231-45. PubMed ID: 19997770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the calcein-AM method assay the total cellular 'labile iron pool' or only a fraction of it?
    Tenopoulou M; Kurz T; Doulias PT; Galaris D; Brunk UT
    Biochem J; 2007 Apr; 403(2):261-6. PubMed ID: 17233627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated ferritin production, iron containment, and oxidant resistance in hemin-treated leukemia cells.
    Lin F; Girotti AW
    Arch Biochem Biophys; 1997 Oct; 346(1):131-41. PubMed ID: 9328293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron availability and complex stability of iron hydroxyethyl starch and iron dextran a comparative in vitro study with liver cells and macrophages.
    Ternes N; Scheiber-Mojdehkar B; Landgraf G; Goldenberg H; Sturm B
    Nephrol Dial Transplant; 2007 Oct; 22(10):2824-30. PubMed ID: 17556418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines.
    Hann HW; Stahlhut MW; Hann CL
    Hepatology; 1990 Apr; 11(4):566-9. PubMed ID: 2158479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1beta increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool.
    Piñero DJ; Hu J; Cook BM; Scaduto RC; Connor JR
    Biochim Biophys Acta; 2000 Sep; 1497(3):279-88. PubMed ID: 10996652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and stability of intravenous iron sucrose originator versus generic iron sucrose AZAD.
    Praschberger M; Cornelius C; Schitegg M; Goldenberg H; Scheiber-Mojdehkar B; Sturm B
    Pharm Dev Technol; 2015 Mar; 20(2):176-82. PubMed ID: 24219061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The labile iron pool of hepatocytes in chronic and acute iron overload and chelator-induced iron deprivation.
    Zanninelli G; Loréal O; Brissot P; Konijn AM; Slotki IN; Hider RC; Ioav Cabantchik Z
    J Hepatol; 2002 Jan; 36(1):39-46. PubMed ID: 11804662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron induction of ferritin synthesis and secretion in human hepatoma cell (Hep G2) cultures.
    Lescoat G; Loreal O; Moirand R; Dezier JF; Pasdeloup N; Deugnier Y; Brissot P
    Liver; 1989 Jun; 9(3):179-85. PubMed ID: 2545999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of parenteral iron preparations on non-transferrin bound iron uptake, the iron regulatory protein and the expression of ferritin and the divalent metal transporter DMT-1 in HepG2 human hepatoma cells.
    Scheiber-Mojdehkar B; Sturm B; Plank L; Kryzer I; Goldenberg H
    Biochem Pharmacol; 2003 Jun; 65(12):1973-8. PubMed ID: 12787877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newly delivered transferrin iron and oxidative cell injury.
    Breuer W; Greenberg E; Cabantchik ZI
    FEBS Lett; 1997 Feb; 403(2):213-9. PubMed ID: 9042969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron sucrose and ferric carboxymaltose: no correlation between physicochemical stability and biological activity.
    Praschberger M; Haider K; Cornelius C; Schitegg M; Sturm B; Goldenberg H; Scheiber-Mojdehkar B
    Biometals; 2015 Feb; 28(1):35-50. PubMed ID: 25326244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.